These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 19696409)

  • 21. Generation of induced pluripotent stem cells from buffalo (Bubalus bubalis) fetal fibroblasts with buffalo defined factors.
    Deng Y; Liu Q; Luo C; Chen S; Li X; Wang C; Liu Z; Lei X; Zhang H; Sun H; Lu F; Jiang J; Shi D
    Stem Cells Dev; 2012 Sep; 21(13):2485-94. PubMed ID: 22420535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reprogramming of human somatic cells to pluripotency with defined factors.
    Park IH; Zhao R; West JA; Yabuuchi A; Huo H; Ince TA; Lerou PH; Lensch MW; Daley GQ
    Nature; 2008 Jan; 451(7175):141-6. PubMed ID: 18157115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reprogramming adipose tissue-derived mesenchymal stem cells into pluripotent stem cells by a mutant adeno-associated viral vector.
    Chen MJ; Lu Y; Hamazaki T; Tsai HY; Erger K; Conlon T; Elshikha AS; Li H; Srivastava A; Yao C; Brantly M; Chiodo V; Hauswirth W; Terada N; Song S
    Hum Gene Ther Methods; 2014 Feb; 25(1):72-82. PubMed ID: 24191859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts.
    Wakao S; Kitada M; Kuroda Y; Shigemoto T; Matsuse D; Akashi H; Tanimura Y; Tsuchiyama K; Kikuchi T; Goda M; Nakahata T; Fujiyoshi Y; Dezawa M
    Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9875-80. PubMed ID: 21628574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4.
    Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P
    Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Derivation, characterization and retinal differentiation of induced pluripotent stem cells.
    Mekala SR; Vauhini V; Nagarajan U; Maddileti S; Gaddipati S; Mariappan I
    J Biosci; 2013 Mar; 38(1):123-34. PubMed ID: 23385820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. iPS cell-derived cardiogenicity is hindered by sustained integration of reprogramming transgenes.
    Martinez-Fernandez A; Nelson TJ; Reyes S; Alekseev AE; Secreto F; Perez-Terzic C; Beraldi R; Sung HK; Nagy A; Terzic A
    Circ Cardiovasc Genet; 2014 Oct; 7(5):667-76. PubMed ID: 25077947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Versatile In Vivo System to Study Myc in Cell Reprogramming.
    Senís E; Mosteiro L; Grimm D; Abad M
    Methods Mol Biol; 2021; 2318():267-279. PubMed ID: 34019296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. iPS cells reprogrammed from human mesenchymal-like stem/progenitor cells of dental tissue origin.
    Yan X; Qin H; Qu C; Tuan RS; Shi S; Huang GT
    Stem Cells Dev; 2010 Apr; 19(4):469-80. PubMed ID: 19795982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oct4-enhanced green fluorescent protein transgenic pigs: a new large animal model for reprogramming studies.
    Nowak-Imialek M; Kues WA; Petersen B; Lucas-Hahn A; Herrmann D; Haridoss S; Oropeza M; Lemme E; Schöler HR; Carnwath JW; Niemann H
    Stem Cells Dev; 2011 Sep; 20(9):1563-75. PubMed ID: 21126163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transgenic mice with defined combinations of drug-inducible reprogramming factors.
    Markoulaki S; Hanna J; Beard C; Carey BW; Cheng AW; Lengner CJ; Dausman JA; Fu D; Gao Q; Wu S; Cassady JP; Jaenisch R
    Nat Biotechnol; 2009 Feb; 27(2):169-71. PubMed ID: 19151700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
    Takahashi K; Yamanaka S
    Cell; 2006 Aug; 126(4):663-76. PubMed ID: 16904174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional cardiomyocytes derived from human induced pluripotent stem cells.
    Zhang J; Wilson GF; Soerens AG; Koonce CH; Yu J; Palecek SP; Thomson JA; Kamp TJ
    Circ Res; 2009 Feb; 104(4):e30-41. PubMed ID: 19213953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of bovine induced pluripotent stem cells by lentiviral transduction of reprogramming factor fusion proteins.
    Cao H; Yang P; Pu Y; Sun X; Yin H; Zhang Y; Zhang Y; Li Y; Liu Y; Fang F; Zhang Z; Tao Y; Zhang X
    Int J Biol Sci; 2012; 8(4):498-511. PubMed ID: 22457605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression Nanog activates pluripotent genes in porcine fetal fibroblasts and nuclear transfer embryos.
    Zhang L; Luo YB; Bou G; Kong QR; Huan YJ; Zhu J; Wang JY; Li H; Wang F; Shi YQ; Wei YC; Liu ZH
    Anat Rec (Hoboken); 2011 Nov; 294(11):1809-17. PubMed ID: 21972213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Derivation of induced pluripotent stem cells from orangutan skin fibroblasts.
    Ramaswamy K; Yik WY; Wang XM; Oliphant EN; Lu W; Shibata D; Ryder OA; Hacia JG
    BMC Res Notes; 2015 Oct; 8():577. PubMed ID: 26475477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of clinically relevant "induced pluripotent stem" (iPS) cells.
    Heffernan C; Sumer H; Verma PJ
    J Stem Cells; 2011; 6(3):109-27. PubMed ID: 23264997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like Cells.
    Ghazizadeh Z; Rassouli H; Fonoudi H; Alikhani M; Talkhabi M; Darbandi-Azar A; Chen S; Baharvand H; Aghdami N; Salekdeh GH
    Mol Biotechnol; 2017 Jun; 59(6):207-220. PubMed ID: 28509990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-phase analysis of molecular pathways underlying induced pluripotent stem cell induction.
    Lin Z; Perez P; Lei D; Xu J; Gao X; Bao J
    Stem Cells; 2011 Dec; 29(12):1963-74. PubMed ID: 21956995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.